RICH
MCID: RPD005
MIFTS: 38

Rapidly Involuting Congenital Hemangioma (RICH)

Categories: Cardiovascular diseases, Fetal diseases, Rare diseases

Aliases & Classifications for Rapidly Involuting Congenital Hemangioma

MalaCards integrated aliases for Rapidly Involuting Congenital Hemangioma:

Name: Rapidly Involuting Congenital Hemangioma 58
Rich 58

Characteristics:

Orphanet epidemiological data:

58
rapidly involuting congenital hemangioma
Inheritance: Not applicable; Age of onset: Infancy,Neonatal;

Classifications:

Orphanet: 58  
Rare circulatory system diseases
Developmental anomalies during embryogenesis


External Ids:

ICD10 via Orphanet 33 D18.0
UMLS via Orphanet 72 C1275421
Orphanet 58 ORPHA141184

Summaries for Rapidly Involuting Congenital Hemangioma

MalaCards based summary : Rapidly Involuting Congenital Hemangioma, also known as rich, is related to hemangioma and congenital hemangioma. The drugs Insulin aspart and Parathyroid hormone have been mentioned in the context of this disorder. Affiliated tissues include bone, liver and skin, and related phenotypes are telangiectasia of the skin and subcutaneous calcification

Wikipedia : 74 A vascular tumor is a tumor of vascular origin; a soft tissue growth that can be either benign or... more...

Related Diseases for Rapidly Involuting Congenital Hemangioma

Diseases related to Rapidly Involuting Congenital Hemangioma via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 18)
# Related Disease Score Top Affiliating Genes
1 hemangioma 10.8
2 congenital hemangioma 10.8
3 non-involuting congenital hemangioma 10.5
4 arteriovenous malformation 10.2
5 thrombocytopenia 10.2
6 posttransplant acute limbic encephalitis 10.2
7 rare tumor 10.2
8 angioma, tufted 10.1
9 deficiency anemia 10.1
10 telangiectasis 10.1
11 vascular cancer 10.1
12 teratoma 10.1
13 fibrosarcoma 10.1
14 congenital fibrosarcoma 10.1
15 cleft lip 10.1
16 hemangioendothelioma 10.1
17 kaposiform hemangioendothelioma 10.1
18 rare vascular tumor 10.1

Graphical network of the top 20 diseases related to Rapidly Involuting Congenital Hemangioma:



Diseases related to Rapidly Involuting Congenital Hemangioma

Symptoms & Phenotypes for Rapidly Involuting Congenital Hemangioma

Human phenotypes related to Rapidly Involuting Congenital Hemangioma:

58 31 (show all 15)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 telangiectasia of the skin 58 31 frequent (33%) Frequent (79-30%) HP:0100585
2 subcutaneous calcification 58 31 frequent (33%) Frequent (79-30%) HP:0007618
3 midfrontal capillary hemangioma 58 31 frequent (33%) Frequent (79-30%) HP:0007466
4 perineal hemangioma 58 31 frequent (33%) Frequent (79-30%) HP:0031449
5 congestive heart failure 58 31 occasional (7.5%) Occasional (29-5%) HP:0001635
6 thrombocytopenia 58 31 occasional (7.5%) Occasional (29-5%) HP:0001873
7 peripheral arteriovenous fistula 58 31 occasional (7.5%) Occasional (29-5%) HP:0100784
8 prominent superficial veins 58 31 occasional (7.5%) Occasional (29-5%) HP:0001015
9 lipoatrophy 58 31 very rare (1%) Very rare (<4-1%) HP:0100578
10 hepatic hemangioma 58 31 very rare (1%) Very rare (<4-1%) HP:0031207
11 avascular necrosis 31 very rare (1%) HP:0010885
12 aseptic necrosis 58 Very rare (<4-1%)
13 hemangioma 58 Obligate (100%)
14 visceral hemangioma 58 Occasional (29-5%)
15 tufted angioma 58 Excluded (0%)

Drugs & Therapeutics for Rapidly Involuting Congenital Hemangioma

Drugs for Rapidly Involuting Congenital Hemangioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 956)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Insulin aspart Approved Phase 4 116094-23-6 16132418
2
Parathyroid hormone Approved, Investigational Phase 4 9002-64-6
3
Asenapine Approved Phase 4 85650-56-2, 65576-45-6 3001386
4
Lactulose Approved Phase 4 4618-18-2 11333
5
Insulin lispro Approved Phase 4 133107-64-9
6
Insulin glulisine Approved Phase 4 207748-29-6
7
Linagliptin Approved Phase 4 668270-12-0 10096344
8
Cimetidine Approved, Investigational Phase 4 51481-61-9 2756
9
leucovorin Approved Phase 4 58-05-9 6006 143
10
Nicotinamide Approved, Investigational Phase 4 98-92-0 936
11
Simvastatin Approved Phase 4 79902-63-9 54454
12
Iron Approved, Experimental Phase 4 7439-89-6, 15438-31-0 23925 27284
13
Magnesium citrate Approved Phase 4 3344-18-1
14
Potassium citrate Approved, Investigational, Vet_approved Phase 4
15 Artichoke Approved Phase 4
16
Artesunate Approved, Investigational Phase 4 88495-63-0 6917864 5464098
17
Primaquine Approved Phase 4 90-34-6 4908
18
Dimenhydrinate Approved Phase 4 523-87-5 441281
19
Ezetimibe Approved Phase 4 163222-33-1 150311
20
Flurbiprofen Approved, Investigational Phase 4 5104-49-4 3394
21
Palonosetron Approved, Investigational Phase 4 135729-61-2, 135729-56-5, 119904-90-4 148211
22
Pentazocine Approved, Vet_approved Phase 4 359-83-1 441278
23
Metronidazole Approved Phase 4 443-48-1 4173
24
Vildagliptin Approved, Investigational Phase 4 274901-16-5 6918537
25
Ciprofloxacin Approved, Investigational Phase 4 85721-33-1 2764
26
Lixisenatide Approved Phase 4 320367-13-3
27
Amodiaquine Approved, Investigational Phase 4 86-42-0 2165
28
Histamine Approved, Investigational Phase 4 51-45-6 774
29
Ribavirin Approved Phase 4 36791-04-5 37542
30
Peginterferon alfa-2b Approved Phase 4 215647-85-1, 99210-65-8
31
Allopurinol Approved Phase 4 315-30-0 2094
32
Bacitracin Approved, Vet_approved Phase 4 1405-87-4 439542 10909430
33
Polymyxin B Approved, Vet_approved Phase 4 1404-26-8
34
Neomycin Approved, Vet_approved Phase 4 1404-04-2 8378
35
Ferrous succinate Approved Phase 4 10030-90-7
36
Xylometazoline Approved, Investigational Phase 4 526-36-3 5709
37
Glimepiride Approved Phase 4 93479-97-1 3476
38
Cilostazol Approved, Investigational Phase 4 73963-72-1 2754
39
Sulfadoxine Approved, Investigational Phase 4 2447-57-6 17134
40
Pyrimethamine Approved, Investigational, Vet_approved Phase 4 58-14-0 4993
41
Hyaluronic acid Approved, Vet_approved Phase 4 9004-61-9 53477741
42
Atorvastatin Approved Phase 4 134523-00-5 60823
43
Sargramostim Approved, Investigational Phase 4 123774-72-1, 83869-56-1
44
Lenograstim Approved, Investigational Phase 4 135968-09-1
45
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
46
Mannitol Approved, Investigational Phase 4 69-65-8 453 6251
47
Guaifenesin Approved, Investigational, Vet_approved Phase 4 93-14-1 3516
48
Probucol Approved, Investigational Phase 4 23288-49-5 4912
49
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
50
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821

Interventional clinical trials:

(show top 50) (show all 2886)
# Name Status NCT ID Phase Drugs
1 Efficacy of Intra-articular Injection of Combined Hyaluronic Acid and Platelet-rich Plasma in Knee Degenerative Joint Disease Unknown status NCT03211650 Phase 4 hyaluronic Acid + platelet-rich plasma;hyaluronic acid;platelet-rich plasma
2 Evaluation of Platelet Rich Fibrin Efficacy on Reduction of Periodontal Problems Unknown status NCT01583491 Phase 4
3 The Effect of Using Autologous Platelet Rich Plasma on Posterior Lumbar Interbody Fusion : a Randomized Comparative Trial Unknown status NCT03261843 Phase 4
4 Evaluating the Efficacy of Different Platelet Rich Plasma (PRP) Treatment Regimens in the Management of Androgenetic Alopecia: an Investigator-initiated, Single-center, Single-blinded, Prospective, Randomized Clinical Trial Unknown status NCT02999737 Phase 4
5 A 104-week, Open-label, Single-group Study: Rosuvastatin Evaluation of Atherosclerotic Chinese Patients (REACH) Unknown status NCT00885872 Phase 4 Rosuvastatin (Crestor)
6 Platelet Rich Fibrin in the Treatment of Palatal Wounds After Epithelialized Free Gingival Grafts Harvesting. A Randomized Clinical Trial Unknown status NCT02438046 Phase 4
7 Does Varying the Chloride Content of Intravenous Fluid Alter the Risk of Acute Kidney Injury After Cardiac Surgery? Unknown status NCT02020538 Phase 4
8 Omega-3 Fatty Acids in First-episode Schizophrenia - a Randomized Controlled Study of Efficacy and Relapse Prevention (OFFER). Rationale, Design, and Methods. Unknown status NCT02210962 Phase 4
9 Low Dose Calcium Supplementation to Prevent Preeclampsia: a Cluster Randomized Study Unknown status NCT02338687 Phase 4
10 An Open-label Switch Study to Asenapine in the Early Stage of Psychosis Unknown status NCT01968161 Phase 4 Asenapine
11 Comparative Study About the Impact of Two Oil Emulsions, One of Them Formulated With MCT, LCT, Olive Oil and Omega 3 Fatty Acids Versus Another One Formulated With MCT and LCT, Administered Intravenously on Severe Acute Pancreatitis Clinical Evolution Unknown status NCT01376817 Phase 4 Fat emulsion with MCT, LCT, olive oil and omega 3 fatty acids;Fat emulsion with MCT and LCT
12 Randomized Clinical Trial of Omega-3 Fatty Acid-supplemented Parenteral Nutrition Versus Standard Parenteral Nutrition in Patients Undergoing Major Laparoscopic Abdominal Surgery Unknown status NCT01819961 Phase 4 MCT/LCT and fish oil;MCT/LCT
13 Delayed Vasospasm After Aneurysm With the Standardization Treatment of Traditional Chinese Medicine Unknown status NCT01840761 Phase 4 herbal drug;placebo
14 Effect of Multi-vitamins With Minerals on Uric Acid Metabolism in Subjects With Hyperuricemia: A Randomized, Double-blinded, Placebo-controlled Trail Unknown status NCT03218709 Phase 4
15 Adjusted Steroid Therapy in Children With Idiopathic Nephrotic Syndrome Unknown status NCT02649413 Phase 4 Prednisone
16 Treatment of Plantar Fasciitis With Injection af Platelet-rich Plasma Into the Origin of the Plantar Fascia - a Prospective, Randomized and Double Blinded Study. Unknown status NCT01509274 Phase 4
17 Phase 4 Study of Vitamin D3 Supplementation for Outcomes in Patients With Unipolar Depression Unknown status NCT01390662 Phase 4
18 Insulin Requirement for Pure- Protein Meal in Children With Type 1 Diabetes Treated With Continuous Subcutaneous Insulin Infusion - a Cross-over, Randomized Trial. Unknown status NCT02685449 Phase 4 Insulin glulisine;Insulin aspart;Insulin lispro
19 Effect of Linagliptin on Intestinal Triglyceride-rich-lipoprotein Metabolism in Type 2 Diabetic Patients Unknown status NCT02280174 Phase 4 linagliptin
20 Prostatic Artery Embolization Versus 532 nm Green Light Laser Photoselective Vaporization of the Prostate for Treating Catheter-Dependent Patients With Benign Prostatic Hyperplasia: A Randomized Controlled Clinical Study Unknown status NCT02006303 Phase 4
21 Pre-hYpertension tReament With A coMbinatIon of Dietary Supplements and Life-style Modifications Unknown status NCT01682291 Phase 4
22 Effects of a Chronical Treatment With Benfotiamine in People With Type 2 Diabetes Mellitus on Pre- and Postprandial Endothelial Function, as Well as on the Function of the Autonomic Nervous System Unknown status NCT00446810 Phase 4 Benfotiamine;Placebo
23 Artemether/ Lumefantrine: A Study of the Effect of Local Food on Pharmacokinetics of Lumefantrine and Population Pharmacokinetics of Lumefantrine Among Ugandan Children Unknown status NCT01944189 Phase 4
24 Effect of Rosuvastatin Therapy on HDL2 Level and Antiatherosclerotic Reverse Cholesterol Transport Process in Chinses CAD Patients With Hyperlipidemia Unknown status NCT02593487 Phase 4 Rosuvastatin 10mg/d group;Rosuvastatin 20mg/d group
25 Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome Unknown status NCT01951001 Phase 4 Prasugrel
26 Effect of Iron Supplementation on Psychomotor Development of Non-anemic Exclusively or Predominantly Breastfed Infants: Randomized, Double-blind, Placebo-controlled Trial. Unknown status NCT02242188 Phase 4 Iron
27 Multicenter Study Evaluating the Efficacy of Dicopeg Junior in Comparison With Lactulose for the Treatment of Functional Constipation in Children Aged 6 Months to 6 Years. A Prospective, Randomized Study. Unknown status NCT03177434 Phase 4 polyethylene glycols (PEG) 3350;Lactulose Oral Product
28 A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF THE SUPPLEMENTATION WITH KIOLIC® IN PATIENTS WITH DIAGNOSIS OF METABOLIC SYNDROME TO IMPROVE ENDOTHELIAL FUNCTION AND INFLAMMATORY STATE. "KYMES" Unknown status NCT01168700 Phase 4 aged garlic extract;Placebo
29 The ACT-OUT Trial: ACTivity OUTcomes Based on the Consumption of a High Carbohydrate or High Fat Diet in Patients With Metabolic Syndrome Unknown status NCT01357382 Phase 4
30 Effect of Platelet Rich Plasma ( PRP ) Applied During Knee Arthroscopy on Pain, Function and Quality of Life - A RCT With a Follow up of 12 Months Completed NCT02189408 Phase 4
31 Platelet Rich Plasma (PRP) in Total Knee Replacement: A Prospective, Randomized, Single-blind, Single-center Clinical Study to Evaluate the Effect of Platelet Rich Plasma (PRP) on Short-term Patient Outcomes Following Total Knee Replacement Completed NCT00826098 Phase 4
32 A Prospective Study to Analyze the Efficacy of IgM Rich Immunoglobulin as an Adjunct to Antibiotics in the Treatment of Bacterial Sepsis in Very Low Birth Weight Preterm Neonates Completed NCT03403530 Phase 4 IgM rich Immunoglobin
33 Impact of Short-term Fructose-enriched Diet on Serum Metabolome by Normal- and Over-weighed Women. Completed NCT03444233 Phase 4
34 Intra-Articular Use of Platelet Rich Plasma Versus Corticosteroid: A Clinical Trials in Osteoarthritis of Knee. Completed NCT03086759 Phase 4 Triamcinolone Hexacetonide
35 Socket Augmentation Using Different Platelet Concentrates, Atorvastatin Gel or Combination (Clinical and Histomorphometric Study) Completed NCT03231137 Phase 4 ATV gel
36 Adjunctive Role of Platelets Rich Fibrin in Palatal Wound Healing After Free Gingival Graft Harvesting - Case Series Completed NCT02521467 Phase 4
37 A Cohort Study to Evaluate the Effect of Vivostat Platelet Rich Fibrin on Diabetic Foot Ulcers. Completed NCT00770939 Phase 4
38 The Effect of Nitrate Supplementation: Source of Supplementation Completed NCT02271633 Phase 4
39 Arthroscopic Rotator Cuff Repair Using Standard Double Row Technique With Platelet Rich Fibrin Membrane vs. Standard Double Row Technique: A Randomized Blinded Outcomes Study Completed NCT02256891 Phase 4
40 Regeneration of the Patellar Tendon After Harvesting Its Central Third With Platelet-rich Plasma. Prospective and Randomized Study. Completed NCT01111747 Phase 4
41 Pilot Study: Randomized Controlled Trial on the Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors Completed NCT00168987 Phase 4 oral nutritional supplement rich in eicosapentanoic acid
42 The Comparison of Knee Osteoarthritis Treatment With Single-dose of Bone Marrow Aspirate Concentrate, Single-dose of Leukocyte Rich Platelet Rich Plasma and 3 Injection of High Molecular Weight Hyaluronic Acid-A Randomized Clinical Trial Completed NCT03825133 Phase 4 Hyaluronic Acid
43 Comparative Study Between Intra Articular Injection of Hyaluronic Acid (HA) With Platelet Rich Plasma (PRP) Versus Genicular Nerve Thermal Radiation in Management of Pain in Knee Osteoarthritis Completed NCT04188561 Phase 4 Intra articular injection Group
44 Socket Augmentation Using Atorvastatin With Or Without PRGF Derived Fibrin Scaffold (Clinical and Histomorphometric Study) Completed NCT03228771 Phase 4 PRGF/ATV;ATV gel
45 Effect of Onion Peel Extract on Endothelial Function and Endothelial Progenitor Cells in Overweight and Obese Subjects Completed NCT02180022 Phase 4 Placebo;Onion peel extract
46 Rosuvastatin 1.2mg in Situ Gel Combined With 1:1 Mixture of Autologous Platelet-rich Fibrin and Porus- Hydroxyappatite Bone Graft in Surgical Treatment of Mandibular Degree II Furcation Defects: A Randomized Clinical Control Trial Completed NCT02369250 Phase 4 Rosuvastatin
47 Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease: Changes in Biomarkers of Oxidative Stress, Profiles of Plasma Amino Acids and Their Derivatives and Brain Function Completed NCT01662414 Phase 4
48 Efficacy and Safety of the Infiltration of Autologous Plasma Rich in Growth Factors (PRGF) in the Symptomatic Treatment of Knee Osteoarthritis Completed NCT00782197 Phase 4
49 Effect of Eicosapentaenoic Acid (EPA) on Major Cardiovascular Events in Hypercholesterolemic Patients: the Japan EPA Lipid Intervention Study (JELIS) Completed NCT00231738 Phase 4 Eicosapentaenoic acid ethyl ester(EPADEL Capsule 300 TM)
50 Value of Liquid Potassium Magnesium Citrate in Controlling Hypertension Completed NCT02653560 Phase 4 Potassium chloride powder;Potassium magnesium Citrate (KMgCit);Potassium citrate powder;Placebo

Search NIH Clinical Center for Rapidly Involuting Congenital Hemangioma

Genetic Tests for Rapidly Involuting Congenital Hemangioma

Anatomical Context for Rapidly Involuting Congenital Hemangioma

MalaCards organs/tissues related to Rapidly Involuting Congenital Hemangioma:

40
Bone, Liver, Skin, Breast, Endothelial, Brain, T Cells

Publications for Rapidly Involuting Congenital Hemangioma

Articles related to Rapidly Involuting Congenital Hemangioma:

(show top 50) (show all 30037)
# Title Authors PMID Year
1
Nucleation of W-Rich Laves Phase Nanoparticles in Tempered Martensite Ferritic Steel During Long-Term Aging at Elevated Temperature. 61
31968503 2020
2
Challenges in CO₂ Reforming with Methane for Production of Hydrogen Rich, Stable Syngas. 61
31748101 2020
3
Trace water activity could improve the formation of 1,3-oleic-2-medium chain-rich triacylglycerols by promoting acyl migration in the lipase RM IM catalyzed interesterification. 61
31935664 2020
4
Vanadate-Rich BiOBr/Bi Nanosheets for Effective Adsorption and Visible-Light-Driven Photodegradation of Rhodamine B. 61
31492236 2020
5
Anthocyanin-rich extract from purple potatoes decreases postprandial glycemic response and affects inflammation markers in healthy men. 61
31818516 2020
6
Low concentration of Fe(II) to enhance the precipitation of U(VI) under neutral oxygen-rich conditions. 61
32000325 2020
7
Identification and functional characterization of the astacidin family of proline-rich host defence peptides (PcAst) from the red swamp crayfish (Procambarus clarkii, Girard 1852). 61
31884202 2020
8
Dual active sites of the Co2N and single-atom Co-N4 embedded in nitrogen-rich nanocarbons: a robust electrocatalyst for oxygen reduction reactions. 61
31860891 2020
9
Jabuticaba residues (Myrciaria jaboticaba (Vell.) Berg) are rich sources of valuable compounds with bioactive properties. 61
31704077 2020
10
Rich yet undocumented ethnozoological practices of socio-culturally diverse indigenous communities of Sikkim Himalaya, India. 61
31730891 2020
11
Plant derived ingredients rich in nitrates or phenolics for protection of pork against protein oxidation. 61
32036925 2020
12
Rich P vacancies modulate Ni2P/Cu3P interfaced nanosheets for electrocatalytic alkaline water splitting. 61
31901594 2020
13
CuS@defect-rich MoS2 core-shell structure for enhanced hydrogen evolution. 61
31911230 2020
14
Tocotrienol-rich fraction from annatto ameliorates expression of lysyl oxidase in human osteoblastic MG-63 cells. 61
31743080 2020
15
Kinetics of biological and chemical processes in anoxic-aerobic digestion of phosphorus rich waste activated sludge. 61
31790887 2020
16
Application of engineered yeast strain fermentation for oligogalacturonides production from pectin-rich waste biomass. 61
31887580 2020
17
Secreted protein acidic and rich in cysteine and cancer: A homeostatic hormone? 61
31955132 2020
18
Platelet-Rich Plasma (PRP) is a Potential Self-Sourced Cognition Booster in Elderly Mice. 61
31939709 2020
19
Development of a digestion method for determining microplastic pollution in vegetal-rich clayey mangrove sediments. 61
31869617 2020
20
Clinical outcomes following injections of leukocyte-rich platelet-rich plasma in osteoarthritis patients. 61
32021021 2020
21
Telemedicine assessment of long-term cognitive and functional status in anti-leucine-rich, glioma-inactivated 1 encephalitis. 61
31848230 2020
22
A novel safety treatment strategy of DEHP-rich flexible polyvinyl chloride waste through low-temperature critical aqueous ammonia treatment. 61
31785902 2020
23
An Uncommon Initial Presentation of T-Cell/Histiocyte-Rich B-Cell Lymphoma: Acute Renal Failure. 61
31876835 2020
24
Cytotoxic, genotoxic and mutagenic evaluation of Alibertia edulis (rich.) a. Rich. ex DC: an indigenous species from Brazil. 61
30044655 2020
25
The expression of Cysteine-Rich Secretory Protein 2 (CRISP2) and miR-582-5p in seminal plasma fluid and spermatozoa of infertile men. 61
31778754 2020
26
Evaluation of the neutralization performances of the industrial waste products (IWPs) in sulphide-rich environment of cemented paste backfill. 61
31929072 2020
27
Effects of in-sewer dosing of iron-rich drinking water sludge on wastewater collection and treatment systems. 61
31877476 2020
28
Treatment of As-rich mine effluents and produced residues stability: Current knowledge and research priorities for gold mining. 61
31884367 2020
29
Acute consumption of flavanol-rich cocoa beverage improves attenuated cutaneous microvascular function in healthy young African Americans. 61
31654654 2020
30
Effect of sinapic acid ester derivatives on the oxidative stability of omega-3 fatty acids rich oil-in-water emulsions. 61
31670124 2020
31
Selenium-Rich-Yeast Protects Against Aluminum-Induced Activating Nuclear Xenobiotic Receptors and Triggering Inflammation and Cytochromes P450 Systems in Mice Heart. 61
31230209 2020
32
Toluene oxidation over Co3+-rich spinel Co3O4: Evaluation of chemical and by-product species identified by in situ DRIFTS combined with PTR-TOF-MS. 61
31884368 2020
33
Glycogen synthase kinase 3 β activity is essential for Polo-like kinase 2- and Leucine-rich repeat kinase 2-mediated regulation of α-synuclein. 61
31881263 2020
34
Synthesis and characterization of a novel magnetic calcium-rich nanocomposite and its remediation behaviour for As(III) and Pb(II) co-contamination in aqueous systems. 61
31841845 2020
35
Rhizosphere modifications of iron-rich minerals and forms of heavy metals encapsulated in sulfidic tailings hardpan. 61
31629592 2020
36
Stepwise recycling of valuable metals from Ni-rich cathode material of spent lithium-ion batteries. 61
31677520 2020
37
Production of H2-rich syngas from gasification of unsorted food waste in supercritical water. 61
31765972 2020
38
Extraction of carotenoid-rich palm pressed fiber oil using mixtures of hydrocarbons and short chain alcohols. 61
31955769 2020
39
Role of autologous platelet-rich fibrin in relocation pharyngoplasty for obstructive sleep apnoea. 61
31272901 2020
40
Production of hydrogen-rich gas from waste rigid polyurethane foam via catalytic steam gasification. 61
32026761 2020
41
Ultrastructural Localization of Histidine-rich Glycoprotein in Skeletal Muscle Fibers: Colocalization With AMP Deaminase. 61
31880188 2020
42
Nitrogen-rich graphitic carbon nitride nanotubes for photocatalytic hydrogen evolution with simultaneous contaminant degradation. 61
31679783 2020
43
A post-transcriptional program of chemoresistance by AU-rich elements and TTP in quiescent leukemic cells. 61
32039742 2020
44
Hydrogen-rich water alleviates cyclosporine A-induced nephrotoxicity via the Keap1/Nrf2 signaling pathway. 61
32040235 2020
45
The 3F Library: Fluorinated Fsp3 -Rich Fragments for Expeditious 19 F NMR Based Screening. 61
31724281 2020
46
In vitro effects of bioflavonoids rich lemon extract on pre-adipocyte differentiation. 61
32009451 2020
47
Oxyamination of Unactivated Alkenes with Electron-Rich Amines and Acids via a Catalytic Triiodide Intermediate. 61
31927966 2020
48
Selenium-rich nickel cobalt bimetallic selenides with core-shell architecture enable superior hybrid energy storage devices. 61
32016240 2020
49
Modulating energetic performance through decorating nitrogen-rich ligands in high-energy MOFs. 61
32016242 2020
50
p53 regulates its own expression by an intrinsic exoribonuclease activity through AU-rich elements. 61
32016559 2020

Variations for Rapidly Involuting Congenital Hemangioma

Expression for Rapidly Involuting Congenital Hemangioma

Search GEO for disease gene expression data for Rapidly Involuting Congenital Hemangioma.

Pathways for Rapidly Involuting Congenital Hemangioma

GO Terms for Rapidly Involuting Congenital Hemangioma

Sources for Rapidly Involuting Congenital Hemangioma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....